February 2020 RHO KINASE INHIBITORS AS A NOVEL TREATMENT FOR GLAUCOMA AND OCULAR HYPERTENSIONFeaturing: Angelo P. Tanna, MD
Episode SummaryAngelo P. Tanna, MD, shares the biggest challenges ophthalmologists face when treating glaucoma and ocular hypertension. He discusses his recently published review of Rho Kinase Inhibitors as a novel treatment for Glaucoma and Ocular Hypertension.
|
Angelo P. Tanna, MD, vice chair and professor in the Department of Ophthalmology at Northwestern Medicine.
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|